Patents by Inventor Vincent Viellard

Vincent Viellard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR THE PROGNOSIS OF PROGRESSION OF THE HIV DISEASE
    Publication number: 20140024018
    Abstract: An in vitro method for the prognosis of progression of an HIV-1 infection in a patient infected with an HIV-1 virus, comprising the steps of: a) measuring the level of antibodies directed against the 3S peptide of SEQ ID NO 2 in a sample collected from the said patient, b) comparing the level of anti-3S antibodies measured at step a) with a reference value of anti-3S antibody level that is indicative of the progression of the HIV-1 infection.
    Type: Application
    Filed: February 21, 2012
    Publication date: January 23, 2014
    Applicants: INNAVIRVAX, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Laurence Meyer, Vincent Viellard, Patrice Debre, Joël Crouzet
  • Purified antibody to the extracellular domain of NKp44L
    Patent number: 8372955
    Abstract: The present invention relates to the field of the in vitro diagnosis of the progression status of an infection of an individual with a virus belonging to the family of the Human Immunodeficiency Viruses (HIV) as well as with the therapeutical treatment of this infectious disease.
    Type: Grant
    Filed: October 29, 2007
    Date of Patent: February 12, 2013
    Assignees: Assistance Publique Hopitaux de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Vincent Viellard, Patrice Debre